Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis
| Autor: | Vagishwari Murugesan, Maira Mirza, Muhammad Mirza, Arrel Olano |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
Infliximab therapy
musculoskeletal diseases History medicine.medical_specialty Necrosis Polymers and Plastics Case Report Pericardial effusion Gastroenterology Industrial and Manufacturing Engineering 03 medical and health sciences 0302 clinical medicine immune system diseases Internal medicine medicine Business and International Management lcsh:RC799-869 Adverse effect skin and connective tissue diseases 030203 arthritis & rheumatology Gastrointestinal tract Systemic lupus erythematosus Hepatology business.industry medicine.disease Ulcerative colitis Infliximab Discontinuation stomatognathic diseases 030211 gastroenterology & hepatology lcsh:Diseases of the digestive system. Gastroenterology medicine.symptom business medicine.drug |
| Zdroj: | Case Reports in Gastrointestinal Medicine, Vol 2018 (2018) Case Reports in Gastrointestinal Medicine |
| ISSN: | 2090-6536 2090-6528 |
| Popis: | Ulcerative colitis is characterized by ulcers and inflammation of the inner lining of the gastrointestinal tract. Antitumor necrosis factor alpha (anti-TNF alpha) agents such as infliximab are drugs that have been used for the treatment of ulcerative colitis for decades. Infliximab is known to be associated with various adverse effects including anti-TNF alpha induced lupus (ATIL). We present a rare case of a 51-year-old female with pericardial effusion secondary to infliximab therapy for treatment of her ulcerative colitis. Discontinuation of infliximab led to resolution of the pericardial effusion. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text